Uterocervical Angle in the Pregnancy Termination of Multiparous Women
Uterocervical Angle in the Termination of Second Trimester Pregnancy in Multiparous Women
1 other identifier
observational
148
1 country
1
Brief Summary
To evaluate the uterocervical angle (UCA) in the prediction of second trimester termination success of multiparous women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 6, 2018
CompletedFirst Posted
Study publicly available on registry
January 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2018
CompletedMarch 6, 2018
March 1, 2018
4 months
January 6, 2018
March 3, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
uterocervical angle
the angle between the cervical canal and anterior uterine wall
1 week
Study Arms (1)
Medical abortion
150 singleton multiparous patients are planning to complete the study period. Study group constitute of second trimester pregnancies between 14-24 weeks of gestation. All participants were multiparous and had no systemic illnesses. The uterocervical angle will be measured in all participants before the induction of labor.
Interventions
the angle between cervical canal and anterior uterine wall is measured sonographically.
Eligibility Criteria
Multiparous pregnant women undergoing medical abortion in the second trimester
You may qualify if:
- multiparous singleton pregnancy
- no previous systemic illnesses
You may not qualify if:
- abnormal Pap smear
- history of dilatation and curettage (D\&C)
- history of LEEP and cervical conization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kanuni SSTRH
Istanbul, Turkey (Türkiye)
Related Links
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Md, ObGYN
Study Record Dates
First Submitted
January 6, 2018
First Posted
January 17, 2018
Study Start
October 1, 2017
Primary Completion
January 31, 2018
Study Completion
February 1, 2018
Last Updated
March 6, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share